Corticosteroids in Respiratory Disorders

Corticosteroids in Respiratory Disorders

Corticosteroids in Respiratory Disorders

On this page

MoA & Classification - Steroid Superpowers

  • Mechanism of Action (MoA): Potent anti-inflammatory.
    • Genomic (slow): Bind cytosolic Glucocorticoid Receptors (GR) → complex to nucleus:
      • ↑ Lipocortin-1 (Annexin A1) → inhibits $PLA_2$ → ↓ PGs, LTs.
      • ↓ Pro-inflammatory genes ($NF-\kappa B$, AP-1 blocked).
    • Non-Genomic (rapid): Via membrane GRs.
  • Types: Glucocorticoids (anti-inflammatory) vs. Mineralocorticoids (salt-retaining). Focus: Glucocorticoids.
  • Classification (Glucocorticoids):
    • Systemic (Oral/IV):
      • Short (8-12h): Hydrocortisone.
      • Intermediate (12-36h): Prednisolone, Methylprednisolone.
      • Long (36-72h): Dexamethasone.
    • Inhaled (ICS): Beclomethasone, Budesonide, Fluticasone (local action, ↓ systemic SEs). 📌 Potency: Hydrocortisone (1) < Prednisolone (4) < Methylprednisolone (5) < Dexamethasone (25).

⭐ Corticosteroids upregulate $\beta_2$-adrenergic receptors, enhancing bronchodilator responsiveness.

Inhaled Corticosteroids (ICS) - Puff Power

  • Common ICS: Beclomethasone, Budesonide, Fluticasone, Ciclesonide, Mometasone.
  • Delivery Devices:
    • MDI: Adv: Portable. Disadv: Needs coordination. Spacer improves delivery, ↓ local S/E.
    • DPI: Adv: Breath-actuated. Disadv: Needs good inspiratory flow.
    • Nebulizers: Adv: For severe attacks/uncooperative patients. Disadv: Less portable. Valved holding chamber with mask components and use
  • Pharmacokinetics:
    • High first-pass metabolism (e.g., Fluticasone, Budesonide) crucial for low systemic effects.
    • Ciclesonide: Prodrug activated in lungs, minimizing local and systemic side effects.
  • Local Side Effects & Prevention:
    • Oropharyngeal candidiasis (thrush), dysphonia (hoarseness).
    • Prevention: Use spacer with MDI; rinse mouth thoroughly with water and spit after inhalation.

Ciclesonide is a prodrug activated in the lungs, minimizing local side effects like candidiasis.

Systemic Steroids: Indications - System Savers

Systemic corticosteroids (Oral - OCS; Intravenous - IVCS) are vital for managing acute and severe respiratory conditions.

  • Core Indications (OCS/IVCS):

    • Acute Severe Asthma: Rapidly reduces airway inflammation and obstruction.
    • COPD Exacerbations: Shortens recovery time, improves FEV1 & PaO2, reduces relapse risk.
    • Chronic Severe Asthma (Refractory): For patients not controlled on high-dose ICS/LABA.
    • Sarcoidosis: Symptomatic pulmonary disease (e.g., Stage II/III with significant symptoms/lung function impairment).
    • Interstitial Lung Diseases (ILDs):
      • Cryptogenic Organizing Pneumonia (COP)
      • Nonspecific Interstitial Pneumonia (NSIP) (especially cellular variant)
    • ARDS (Acute Respiratory Distress Syndrome): Selected cases (e.g., early moderate-severe ARDS, COVID-19 related), benefits controversial, dose & timing critical.
  • Dosing Principles & Examples:

    • "Burst" Therapy (Acute Exacerbations):
      • Prednisolone (Oral): 40-50 mg/day for 5-7 days (Asthma/COPD). No tapering needed for short courses.
    • Longer Courses (>2-3 weeks): Gradual tapering is essential to prevent adrenal insufficiency.
    • Route Selection:
      • Oral (PO): Prednisolone is preferred if patient can tolerate oral intake.
      • Intravenous (IV): Methylprednisolone (e.g., 60-128 mg/day in divided doses for severe asthma), Hydrocortisone (e.g., 100-200 mg IV stat then q6h for status asthmaticus). Use for severe cases or if unable to take orally.

⭐ For acute asthma exacerbations, oral corticosteroids are as effective as intravenous corticosteroids if the patient can tolerate oral intake and there are no concerns about absorption.

Flowchart: Steroid Use in Acute Asthma Exacerbation

Adverse Effects & Management - Steroid Alerts

Effect TypeAdverse EffectsPrevention / Management
Local (ICS)Oropharyngeal candidiasis, dysphonia, cough.Spacer, mouth rinsing.
Systemic (OCS / High-dose ICS)HPA axis suppression, Cushingoid features (📌 CUSHINGOID), osteoporosis, hyperglycemia, immunosuppression, cataracts, glaucoma, skin thinning, mood changes, PUD.Lowest effective dose, shortest duration, calcium/Vit D, bone density monitoring, PPI if needed, regular check-ups.

Key Cautions:

  • Active untreated infections (esp. TB, fungal), live vaccines (with high dose systemic), peptic ulcer disease, uncontrolled diabetes/hypertension.

Steroid Withdrawal Syndrome:

  • Abrupt cessation: fatigue, myalgia, arthralgia, hypotension. Taper dose.

⭐ Alternate day therapy with short-acting oral corticosteroids like prednisolone can reduce HPA axis suppression in long-term use.

High‑Yield Points - ⚡ Biggest Takeaways

  • Inhaled Corticosteroids (ICS) like Budesonide & Fluticasone are first-line for persistent asthma.
  • Systemic corticosteroids (e.g., Prednisolone) manage acute asthma/COPD exacerbations.
  • MOA: Broad anti-inflammatory effects, ↓ cytokines & eosinophils.
  • ICS adverse effects: Oral thrush, dysphonia; mitigate with spacer & mouth rinsing.
  • Systemic risks: Hyperglycemia, osteoporosis, HPA axis suppression, immunosuppression.
  • Budesonide is the safest ICS during pregnancy.
  • Also indicated for ABPA and pulmonary sarcoidosis.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Corticosteroids in Respiratory Disorders

Test your understanding with these related questions

A 3-year-old is diagnosed with severe acute asthma exacerbation. Which medication is given first?

1 of 5

Flashcards: Corticosteroids in Respiratory Disorders

1/10

_____ is a systemic steroid used for maintenance therapy after an acute exacerbation of asthma.

TAP TO REVEAL ANSWER

_____ is a systemic steroid used for maintenance therapy after an acute exacerbation of asthma.

Prednisolone

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free